Humanisation And Pre-clinical Validation Of A Therapeutic Anti-cancer Antibody
Funder
National Health and Medical Research Council
Funding Amount
$699,136.00
Summary
This grant will develop a novel antibody against a protease expressed on cancer cells. Preclinical studies, and antibody humanisation, will be performed. This project will also provide vital information on optimal therapeutic approaches with the antibody that can be ultimately taken into human trials.
We have discovered a single tumour factor which causes cancer cachexia, a wasting condition that is one of the worst complications of malignancy, for which there is no current effective treatment. We have developed antibodies which effectively block this condition in preclinical models and have produced human/humanised version of this. This application is to characterise these human antibodies to allow us proceed to clinical trials.
Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.
Heparin-induced Thrombocytopenia And Thrombosis: Better Understanding Of Pathogenesis And Improving Diagnosis And Treatment
Funder
National Health and Medical Research Council
Funding Amount
$653,137.00
Summary
Heparin, a widely used drug, can cause an adverse effect which results in a fall of the platelet count and the development of serious thrombosis. This drug complication is mediated by an immune mechanism. This proposal aims to provide a better understanding of the disease mechanism. It also aims to develop a new test that will improve the diagnosis, and to produce a novel drug that will effectively suppress the immune reaction and improve the treatment.
ADAM Metalloprotease Inhibition For Treatment Of Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$770,925.00
Summary
Colorectal cancer (CRC) causes over 4000 deaths/year, typically from developing drug resistance and spreading to other organs (metastasis). These processes involve tumour cells called cancer stem cells (CSCs), which rely on specific cell surface proteins for survival and function. We are developing antibodies against one of these type of proteins, to test in mouse models of CRC. These already show promise in targeting CSCs and inhibiting drug-resistance and metastasis in mice.
Economically efficient green logistics through cyber physical systems. Economically efficient green logistics through cyber physical systems. This project aims to realize green logistics by researching how to run diesel-powered heavy-duty milk trucks economically and efficiently on liquefied natural gas (LNG) and demonstrating to logistics companies that LNG conversion will reduce operating costs and emissions. Transportation systems account for 18% of Australia's carbon emissions, and diesel-po ....Economically efficient green logistics through cyber physical systems. Economically efficient green logistics through cyber physical systems. This project aims to realize green logistics by researching how to run diesel-powered heavy-duty milk trucks economically and efficiently on liquefied natural gas (LNG) and demonstrating to logistics companies that LNG conversion will reduce operating costs and emissions. Transportation systems account for 18% of Australia's carbon emissions, and diesel-powered logistics vehicles are a major contributor. However, converting these trucks to LNG requires strong evidence to convince logistics companies of the benefits of shifting to green logistics. An increase in logistics productivity is expected to increase Australia’s gross domestic product by $2 billion, while this research should also provide vital data on sustainability issues and LNG conversions.Read moreRead less
A NOVEL MOUSE MODEL TO INVESTIGATE THE MECHANISMS OF VIRUS-INDUCED ARTHRITIS
Funder
National Health and Medical Research Council
Funding Amount
$336,000.00
Summary
We have developed a novel animal model by which to study arthritic disease caused by insect-transmitted viruses known as arboviruses. The existence of this model and novel reagents provides an excellent opportunity to further explore the basic mechanisms of infectious disease in a complete functioning animal, rather than specific cultured cells. The study will use modern approaches in molecular and cellular biology to achieve this goal. The production by our immune systems of soluble mediators ( ....We have developed a novel animal model by which to study arthritic disease caused by insect-transmitted viruses known as arboviruses. The existence of this model and novel reagents provides an excellent opportunity to further explore the basic mechanisms of infectious disease in a complete functioning animal, rather than specific cultured cells. The study will use modern approaches in molecular and cellular biology to achieve this goal. The production by our immune systems of soluble mediators (cytokines-chemokines) and antibodies is an overwhelming positive aspect of our physiological response to infection by microbes. Protection from disease by these immune compounds can happen naturally, or the body's ability to produce these factors can be exploited to our benefit via the administration of vaccines. However, these factors can also be detrimental to the host contributing to severe disease. For instance, work performed almost 40 years ago showed for the first time that under particular conditions, antibodies against viruses can enhance infection, instead of inhibiting infection as normally seen. In the intervening years work by scientists all over the world has associated antibody-dependent enhancement (ADE) of infection to many types of viruses; ADE is even thought to be a risk factor to serious disease with dengue virus, and has been shown in vitro for the AIDS virus and Ebola virus. We have recently discovered a molecular mechanism which explains how antibody enhances viral infection in vitro. In studies on immune cells infected with Ross River Virus (RRV) we found that infection helped by antibody resulted in the specific disruption to the production of cellular chemicals which are toxic to viruses. Are these mechanisms of antibody-enhanced infection also found in animals? Will such mode of infection cause enhanced disease and tissue pathology (arthritis) in animals?Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC140100032
Funder
Australian Research Council
Funding Amount
$2,119,872.00
Summary
ARC Training Centre for Food and Beverage Supply Chain Optimisation. ARC Training Centre for Food and Beverage Supply Chain Optimisation. With 15 per cent of the Australian workforce involved in food production and annual food exports of $30.5 billion, the food industry is clearly vital to the Australian economy. The National Food Plan White Paper states as a goal for 2025: "The value of Australia's agriculture and food-related exports will have increased by 45 per cent (in real terms), contribu ....ARC Training Centre for Food and Beverage Supply Chain Optimisation. ARC Training Centre for Food and Beverage Supply Chain Optimisation. With 15 per cent of the Australian workforce involved in food production and annual food exports of $30.5 billion, the food industry is clearly vital to the Australian economy. The National Food Plan White Paper states as a goal for 2025: "The value of Australia's agriculture and food-related exports will have increased by 45 per cent (in real terms), contributing to an increase in our gross domestic product." To make these aspirations a reality, safe, sustainable, and cost-effective, food supply chains will be essential. The Training Centre will train the next generation of multi-disciplinary researchers capable of designing and managing these supply chains.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC190100026
Funder
Australian Research Council
Funding Amount
$4,969,663.00
Summary
ARC Training Centre for Cell and Tissue Engineering Technologies. The ARC Training Centre for Cell and Tissue Engineering Technologies aims to provide training to create a highly skilled workforce for the tissue engineering and regenerative medicine sector and to enhance research performance and innovation in Australia through fundamental and applied research carried out in industry-led PhD projects. The research aims to address major aspects of the manufacturing and commercialisation pathway an ....ARC Training Centre for Cell and Tissue Engineering Technologies. The ARC Training Centre for Cell and Tissue Engineering Technologies aims to provide training to create a highly skilled workforce for the tissue engineering and regenerative medicine sector and to enhance research performance and innovation in Australia through fundamental and applied research carried out in industry-led PhD projects. The research aims to address major aspects of the manufacturing and commercialisation pathway and barriers faced by the sector, namely improving process efficiencies, enabling early-stage scale-up (cell/tissue) and development of the sector's supply chain. The knowledge created and research undertaken would help to accelerate commercialisation in regenerative medicine, tissue engineering and cell therapies.Read moreRead less
Mathematics and computing for integrated stockyard-centric management of mining supply chains. Blended mineral products, such as coal and iron ore, make a strong contribution to Australia's economy. Blending occurs in stockpiles, so to realise product value, stockyard and supply chain operational plans must align with blend targets. This project will provide new mathematical and computational planning tools to maximise this value.